Passions

Clemson Football

Arsenal FC

Travel

Experience

Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management

August 28, 2025

Cooley advised Eagle Pharmaceuticals, a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise, on its cooperation agreement with Nantahala Capital Management, a holder of approximately 38% of Eagle’s outstanding shares.

Read more

Related contacts

Bill Roegge
Partner, New York
Sarah Sellers
Partner, New York
Marc Recht
Partner, Boston
Pat O'Connell
Associate, New York
Asa Henin
Partner, San Diego
Paul Alexander
Associate, Washington, DC
Nathan Baum
Special Counsel, New York
Luke Cadigan
Partner in Charge – Boston, Boston
Tijana Brien
Partner, Palo Alto
Ariane A. Andrade
Partner, Chicago

Related Practices & Industries

Packable Agrees to SPAC Merger With Highland Transcend Partners | Corp.

September 14, 2021

Cooley advised Packable, the holding company for technology-led ecommerce marketplace enablement platform Pharmapacks, on its definitive agreement to merge with special purpose acquisition company (SPAC) Highland Transcend Partners I Corp. Partners Sacha Ross, David Silverman, Nicolas Dumont and Stephanie Gentile led the Cooley team advising Packable.

Read more

Related contacts

Sacha Ross
Partner, New York
David Silverman
Partner, New York
Stephanie Gentile
Partner, New York
Ariel Rom
Partner, New York
David Dalton
Associate, Santa Monica
Scott D. Rudin
Associate, New York
Miguel J. Vega
Partner, Boston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Paul Alexander
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Sonia Nath
Partner, Washington, DC

Related Practices & Industries

MaxCyte – $202 Million IPO

July 30, 2021

Cooley advised MaxCyte on its $201.8 million initial public offering of 15,525,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. MaxCyte, whose securities now trade on the Nasdaq Global Select Market under the symbol “MXCT,” also trades on the London Stock Exchange under the symbols "MXCT" and "MXCN." MaxCyte is a leading provider of cell-engineering platform technologies. Partners Christian Plaza, Brian Leaf and Claire Keast-Butler led the Cooley team.

Related contacts

Christian Plaza
Partner, Reston
Claire Keast-Butler
Co-Partner in Charge – London, London
Katie Kazem
Partner, Reston
Paul Alexander
Associate, Washington, DC
Div Gupta
Partner, New York
Madison Jones
Partner, Washington, DC
Denny Xu
Associate, Boston

Related Practices & Industries

Admissions and credentials

District of Columbia

New York

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.